• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Bio-Rad Laboratories Inc.

    10/10/24 11:36:31 AM ET
    $BIO.B
    Get the next $BIO.B alert in real time by email
    SC 13G 1 bio_101024.htm BANK OF NOVA SCOTIA bio_101024.htm
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 13G
    Under the Securities Exchange Act of 1934
    BIO-RAD LABORATORIES
    (Name of Issuer)
    Common Shares
    (Title of Class of Securities)
    90572207
    (CUSIP Number)
    December 30, 2022
    (Date of Event which Requires Filing of this Statement)
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    [X] Rule 13d-1(b)
    [   ] Rule 13d-1(c)
    [   ] Rule 13d-1(d)
    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see Instructions).
    CUSIP No.: 90572207
           
    1
    NAME OF REPORTING PERSON
    The Bank of Nova Scotia
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) [   ]
    (b) [   ]
    3 SEC USE ONLY
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
    Canada
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5
    SOLE VOTING POWER
    1,604,046
    6
    SHARED VOTING POWER
    0
    7
    SOLE DISPOSITIVE POWER
    1,604,046
    8
    SHARED DISPOSITIVE POWER
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    1,604,046
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
    [   ]
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
    6.5%
    12
    TYPE OF REPORTING PERSON
    FI
    Reporting Persons beneficial ownership relating to this issuer for year-end 2022.
    CUSIP No.: 90572207
    ITEM 1(a). NAME OF ISSUER:
    BIO-RAD LABORATORIES
    ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
    1000 Alfred Nobel Dr.
    Hercules, California 94547
    ITEM 2(a). NAME OF PERSON FILING:
    The Bank of Nova Scotia
    ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
    40 Temperance Street, Toronto, Ontario, M5H 0B4
    ITEM 2(c). CITIZENSHIP:
    Canada
    ITEM 2(d). TITLE OF CLASS OF SECURITIES:
    Common Shares
    ITEM 2(e). CUSIP NUMBER:
    90572207
    ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A:
    (a)
    [ ]
    Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c);
    (b)
    [ ]
    Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)
    [ ]
    Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)
    [ ]
    Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
    (e)
    [ ]
    An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
    (f)
    [ ]
    An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
    (g)
    [ ]
    A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
    (h)
    [ ]
    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)
    [ ]
    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)
    [X]
    A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J);
    (k)
    [ ]
    Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution:
    g
    ITEM 4. OWNERSHIP
    (a) Amount beneficially owned:
    1,604,046
    (b) Percent of class:
    6.5%
    (c) Number of shares as to which the person has:
    (i) sole power to vote or to direct the vote:
    The Bank of Nova Scotia : 1,604,046
    (ii) shared power to vote or to direct the vote:
    The Bank of Nova Scotia : 0
    (iii) sole power to dispose or direct the disposition of:
    The Bank of Nova Scotia : 1,604,046
    (iv) shared power to dispose or to direct the disposition of:
    The Bank of Nova Scotia : 0
    ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].
    ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
    N/A
    ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY:
    N/A
    ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
    N/A
    ITEM 9. NOTICE OF DISSOLUTION OF GROUP:
    N/A
    ITEM 10. CERTIFICATION:
    By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to insert particular category of institutional investor is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.
    CUSIP No.: 90572207
    SIGNATURE
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
    October 10 2024
    The Bank of Nova Scotia
    By:
    /s/ George Jones
    Name:
    George Jones
    Title:
    Senior Vice President, Compliance GBM and Treasury
    Attention — Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).
    Get the next $BIO.B alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BIO.B

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BIO.B
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, President, LSG Barry James sold $214,289 worth of Bio-Rad A Common Stock (700 units at $306.18), decreasing direct ownership by 58% to 510 units (SEC Form 4)

    4 - BIO-RAD LABORATORIES, INC. (0000012208) (Issuer)

    11/10/25 4:15:49 PM ET
    $BIO.B

    President & COO Divincenzo Jonathan P. converted options into 1,869 units of Bio-Rad A Common Stock and covered exercise/tax liability with 950 units of Bio-Rad A Common Stock (SEC Form 4)

    4 - BIO-RAD LABORATORIES, INC. (0000012208) (Issuer)

    10/28/25 12:29:44 PM ET
    $BIO.B

    EVP, Global Supply Chain Evran Sedat converted options into 1,044 units of Bio-Rad A Common Stock and covered exercise/tax liability with 335 units of Bio-Rad A Common Stock, increasing direct ownership by 47% to 2,233 units (SEC Form 4)

    4 - BIO-RAD LABORATORIES, INC. (0000012208) (Issuer)

    10/21/25 4:42:00 PM ET
    $BIO.B

    $BIO.B
    SEC Filings

    View All

    SEC Form 144 filed by Bio-Rad Laboratories Inc.

    144 - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

    11/6/25 4:24:39 PM ET
    $BIO.B

    SEC Form 10-Q filed by Bio-Rad Laboratories Inc.

    10-Q - BIO-RAD LABORATORIES, INC. (0000012208) (Filer)

    10/29/25 4:18:31 PM ET
    $BIO.B

    Bio-Rad Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - BIO-RAD LABORATORIES, INC. (0000012208) (Filer)

    10/29/25 4:16:49 PM ET
    $BIO.B

    $BIO.B
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Element Biosciences and Bio-Rad Partner to Deliver Seamless RNA Sequencing Workflow Between Element's AVITI™ System and Bio-Rad's SEQuoia™ Express and SEQuoia™ Complete Stranded RNA Library Prep Kits

    SAN DIEGO and HERCULES, Calif., Feb. 8, 2023 /PRNewswire/ -- Element Biosciences, Inc. — the developer of an innovative DNA sequencing platform disrupting genomics — and Bio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostic products, today announced a partnership to demonstrate the capabilities of the Bio-Rad SEQuoia RNA Sequencing Library Preparation portfolio on the Element AVITI™ Benchtop Sequencer. The Element AVITI Sequencing Platform's novel Avidity Sequencing chemistry can be easily adapted for use with the Bio-Rad SEQuo

    2/8/23 8:00:00 AM ET
    $BIO
    $BIO.B
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $BIO.B
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Bio-Rad Laboratories Inc.

    SC 13G - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

    11/14/24 5:25:27 PM ET
    $BIO.B

    Amendment: SEC Form SC 13G/A filed by Bio-Rad Laboratories Inc.

    SC 13G/A - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

    11/12/24 1:27:07 PM ET
    $BIO.B

    Amendment: SEC Form SC 13G/A filed by Bio-Rad Laboratories Inc.

    SC 13G/A - BIO-RAD LABORATORIES, INC. (0000012208) (Subject)

    11/4/24 11:22:04 AM ET
    $BIO.B